Schedules of controlled substances: Zalepon; placement into Schedule IV; correction,

[Federal Register: May 11, 1999 (Volume 64, Number 90)]

[Corrections]

[Page 25405]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr11my99-145]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA-182P]

21 CFR Part 1308

Schedules of Controlled Substances: Proposed Placement of Zaleplon into Schedule IV

Correction

In proposed rule document 99-11289, beginning on page 24094 in the issue of Wednesday May 5, 1999, make the following corrections:

1. On page 24094, in the third column, beginning in the eighth line from the bottom, the sentence ``Zaleplon-related overdoes were also noted during the clinical trials'' is removed.

2. On the same page, in the same column, in the fifth line from the bottom, ``overdoes'' should read ``overdoses''.

[FR Doc. C9-11289Filed5-10-99; 8:45 am]

BILLING CODE 1505-01-D